Author: todaychina

Live-action prototype of Disney's animated 'Snow White' dies at age 101

Live-action prototype of Disney’s animated ‘Snow White’ dies at age 101

According to foreign media reports, the famous dancer, the live prototype of the classic Disney animation “Snow White” as the…

Walmart sues U.S. government for trying to "shrug off" drug abuse crisis

Walmart sues U.S. government for trying to “shrug off” drug abuse crisis

Wal-Mart, the largest U.S. department store chain, has filed a lawsuit against the U.S. government, accusing it of trying to…

Hedge fund guru: Big Democratic win may lead to short-term market rally

Billionaire hedge fund investor Paul Tudor Jones said Thursday that a Democratic victory in the general election could cause the…

SANA: No V-shaped recovery but short-lived rebound in US economy

White House economic adviser Larry Kudlow (Larry Kudlow) insisted that the United States economy is in a “V” type recovery….

Ireland or Britain’s “no-deal Brexit” biggest loser

Central Bank of Ireland governor Gabriel Mahlouf said, if the United Kingdom “no deal” from the European Union, Ireland may…

The Economist UK: Contagion has not triggered emerging market crisis

Reference News (Oct. 23, 2009) reports that the following is an excerpt from the article “New Coronary Pneumonia Has Not…

British media: China’s rise and US fears of decline

In his landmark study, economic historian Joel Morkiel noted that “the most predictive factor of the standard of living a…

Compared to A-shares, Hong Kong stocks currently have the following advantages

Hong Kong stocks currently have the following advantages over A-shares. Hong Kong stocks include leading Chinese technology companies in high…

The time for an energy revolution has come

#Dialogue Lu Bin #We believe that the era of the energy revolution has arrived, new energy alternative to traditional energy…

Raltegravir Receives Official FDA Authorization, Becomes First U.S. Drug Approved for New Crown Treatment

Raltegravir Receives Official FDA Authorization, Becomes First U.S. Drug Approved for New Crown Treatment

U.S. Food and Drug Administration approves Radicevir for the treatment of neo-crown hospitalized patients. On Oct. 22, the U.S. Food…